These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 26513225

  • 1. Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1-ABCG2 signaling.
    Su J, Wu S, Tang W, Qian H, Zhou H, Guo T.
    Mol Carcinog; 2016 Nov; 55(11):1822-1832. PubMed ID: 26513225
    [Abstract] [Full Text] [Related]

  • 2. The effects and mechanisms of SLC34A2 on tumorigenicity in human non-small cell lung cancer stem cells.
    Jiang Z, Hao Y, Ding X, Zhang Z, Liu P, Wei X, Xi J.
    Tumour Biol; 2016 Aug; 37(8):10383-92. PubMed ID: 26846105
    [Abstract] [Full Text] [Related]

  • 3. SLC27A2 regulates miR-411 to affect chemo-resistance in ovarian cancer.
    Chen FD, Chen HH, Ke SC, Zheng LR, Zheng XY.
    Neoplasma; 2018 Nov 15; 65(6):915-924. PubMed ID: 30334452
    [Abstract] [Full Text] [Related]

  • 4. Activated leukocyte cell adhesion molecule (CD166): an "inert" cancer stem cell marker for non-small cell lung cancer?
    Tachezy M, Zander H, Wolters-Eisfeld G, Müller J, Wicklein D, Gebauer F, Izbicki JR, Bockhorn M.
    Stem Cells; 2014 Jun 15; 32(6):1429-36. PubMed ID: 24501004
    [Abstract] [Full Text] [Related]

  • 5. Upregulated miR-132 in Lgr5+ gastric cancer stem cell-like cells contributes to cisplatin-resistance via SIRT1/CREB/ABCG2 signaling pathway.
    Zhang L, Guo X, Zhang D, Fan Y, Qin L, Dong S, Zhang L.
    Mol Carcinog; 2017 Sep 15; 56(9):2022-2034. PubMed ID: 28383763
    [Abstract] [Full Text] [Related]

  • 6. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
    Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, Roz E, Caserini R, Lo Vullo S, Camerini T, Mariani L, Delia D, Calabrò E, Pastorino U, Sozzi G.
    Proc Natl Acad Sci U S A; 2009 Sep 22; 106(38):16281-6. PubMed ID: 19805294
    [Abstract] [Full Text] [Related]

  • 7. Upregulation of miR-199a/b contributes to cisplatin resistance via Wnt/β-catenin-ABCG2 signaling pathway in ALDHA1+ colorectal cancer stem cells.
    Chen B, Zhang D, Kuai J, Cheng M, Fang X, Li G.
    Tumour Biol; 2017 Jun 22; 39(6):1010428317715155. PubMed ID: 28639895
    [Abstract] [Full Text] [Related]

  • 8. Targeting CD166+ lung cancer stem cells: Molecular study using murine dendritic cell vaccine.
    El-Ashmawy NE, Salem ML, Abd El-Fattah EE, Khedr EG.
    Toxicol Appl Pharmacol; 2021 Oct 15; 429():115699. PubMed ID: 34437932
    [Abstract] [Full Text] [Related]

  • 9. CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/β-catenin-FoxM1-Twist signaling.
    Su J, Wu S, Wu H, Li L, Guo T.
    Mol Carcinog; 2016 Dec 15; 55(12):1962-1973. PubMed ID: 26621583
    [Abstract] [Full Text] [Related]

  • 10. ABCG2 regulates the pattern of self-renewing divisions in cisplatin-resistant non-small cell lung cancer cell lines.
    Tang Y, Hou J, Li G, Song Z, Li X, Yang C, Liu W, Hu Y, Xu Y.
    Oncol Rep; 2014 Nov 15; 32(5):2168-74. PubMed ID: 25200103
    [Abstract] [Full Text] [Related]

  • 11. shRNA targeting Bmi1 impedes the self-renewal of cisplatin-enriched stem-like cells in human A549 cells.
    Xu Y, Hu YD, Zhou J, Zhang MH, Yuan WW, Luo Y.
    Oncol Rep; 2012 Aug 15; 28(2):629-39. PubMed ID: 22664532
    [Abstract] [Full Text] [Related]

  • 12. Uncoupling protein 2 downregulation by hypoxia through repression of peroxisome proliferator-activated receptor γ promotes chemoresistance of non-small cell lung cancer.
    Wang M, Li G, Yang Z, Wang L, Zhang L, Wang T, Zhang Y, Zhang S, Han Y, Jia L.
    Oncotarget; 2017 Jan 31; 8(5):8083-8094. PubMed ID: 28042952
    [Abstract] [Full Text] [Related]

  • 13. MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6.
    Yang L, Lin Z, Wang Y, Gao S, Li Q, Li C, Xu W, Chen J, Liu T, Song Z, Liu G.
    Mol Carcinog; 2018 Mar 31; 57(3):419-428. PubMed ID: 29144562
    [Abstract] [Full Text] [Related]

  • 14. The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics.
    Liu A, Feng B, Gu W, Cheng X, Tong T, Zhang H, Hu Y.
    Int J Oncol; 2013 Apr 31; 42(4):1399-407. PubMed ID: 23416969
    [Abstract] [Full Text] [Related]

  • 15. JARID2 promotes stemness and cisplatin resistance in non-small cell lung cancer via upregulation of Notch1.
    Wang Q, Wu J, Wei H, Huang H, Huang Y, Fang H, Gong X, Sun J, Wu Y, Lei C, Yu J, Hu D.
    Int J Biochem Cell Biol; 2021 Sep 31; 138():106040. PubMed ID: 34246759
    [Abstract] [Full Text] [Related]

  • 16. Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling.
    Ge G, Zhou C, Ren Y, Tang X, Wang K, Zhang W, Niu L, Zhou Y, Yan Y, He J.
    Tumour Biol; 2016 Apr 31; 37(4):5049-62. PubMed ID: 26546432
    [Abstract] [Full Text] [Related]

  • 17. Ultrasound reverses chemoresistance in breast cancer stem cell like cells by altering ABCG2 expression.
    Guo L, Zheng P, Fan H, Wang H, Xu W, Zhou W.
    Biosci Rep; 2017 Dec 22; 37(6):. PubMed ID: 28935760
    [Abstract] [Full Text] [Related]

  • 18. ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling.
    Vesel M, Rapp J, Feller D, Kiss E, Jaromi L, Meggyes M, Miskei G, Duga B, Smuk G, Laszlo T, Karner I, Pongracz JE.
    Respir Res; 2017 Mar 24; 18(1):52. PubMed ID: 28340578
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.